Evidence map›Paper›PMID 31035100›Full record

ArticleThe Journal of nutritional biochemistry2019

Alterations in folate-dependent one-carbon metabolism as colon cell transition from normal to cancerous.

I Asante, D Chui, H Pei, E Zhou, C De Giovanni, D Conti, S Louie

Open access · greenAbstract read
In one paragraph

Article in The Journal of nutritional biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

I AsanteDepartment of Clinical Pharmacy, USC School of Pharmacy, Los Angeles, CA 90033, USA. Electronic address: asante46@yahoo.com.
D ChuiDepartment of Clinical Pharmacy, USC School of Pharmacy, Los Angeles, CA 90033, USA.
H PeiDepartment of Clinical Pharmacy, USC School of Pharmacy, Los Angeles, CA 90033, USA.
E ZhouDepartment of Clinical Pharmacy, USC School of Pharmacy, Los Angeles, CA 90033, USA.
C De GiovanniDepartment of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
D ContiDepartment of Preventive Medicine, USC Keck School of Medicine, Los Angeles, CA 90033, USA.
S LouieDepartment of Clinical Pharmacy, USC School of Pharmacy, Los Angeles, CA 90033, USA.
LAC+USC Medical Center · USKeck Hospital of USC · USUniversity of Bologna · IT

Funding

Incorporating intermediate biomarkers of folate with colorectal cancerR01CA140561 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CONTI, DAVID V, SCHUMACHER, FREDRICK RAY · 2011 to 2015
$1.9M
Imputation-based approach to identify low frequency variants in prostate cancerU01CA188392 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SCHUMACHER, FREDRICK RAY · 2014 to 2016
$1.9M
NCI NIH HHS R01 CA140561NCI NIH HHS U01 CA188392
6 · The paper itself

Abstract

Folate-dependent one-carbon cycle metabolism (FOCM) plays a critical role in maintaining genomic stability through regulating DNA biosynthesis, repair and methylation. Folate metabolites as well as other metabolites in the FOCM are hypothesized to be altered when cells transition from normal to cancerous state. Using cells at different stages in their development into colorectal cancer, the FOCM metabolites were profiled as an effort to phenotype the cells, and the metabolite levels were compared to the expressions of related genes. Here, we investigate whether there is a correlation between the metabolite levels, DNA methylation levels and the expression of the related genes that drive the levels of these metabolites. Using CRL1459, APC10.1

Indexed as

Caco-2 CellsCarbonCell ProliferationCell Transformation, NeoplasticColonDNA MethylationFerredoxin-NADP ReductaseFolate Receptor 1Folic AcidGene Expression RegulationGlycine HydroxymethyltransferaseHCT116 CellsHumansCarbonFerredoxin-NADP ReductaseFolate Receptor 1Folic AcidFOLR1 protein, humanGlycine Hydroxymethyltransferasemethionine synthase reductaseSHMT protein, humanColorectal cancerDNA methylationFolateMetabolomicsOne-carbon cycle

Identifiers

PMID31035100
PMCPMC6570572
OpenAlexW2921711278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.